Dow Down 0.18% Nasdaq Up 0.39%

Exelixis, Inc. (EXEL)

-NasdaqGS
1.85 Down 2.29(55.31%) 4:00PM EDT
|After Hours : 1.86 Up 0.01 (0.54%) 5:26PM EDT - Nasdaq Real Time Price
Prev Close:4.14
Open:1.90
Bid:1.85 x 1500
Ask:1.86 x 1500
1y Target Est:5.93
Beta:1.96
Earnings Date:Oct 28 - Nov 3 (Est.)
Day's Range:1.84 - 2.06
52wk Range:1.84 - 8.41
Volume:43,220,228
Avg Vol (3m):3,806,040
Market Cap:360.95M
P/E (ttm):N/A
EPS (ttm):-1.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Comparison

Symbol% ChgMkt Cap
EXELDown 55.31%360.95M
AZNDown 1.80%94.27B
GSKDown 1.65%115.99B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):37.96
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.54
Quarterly EPS Est (Sep-14) :-0.39
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):0.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Exelixis, Inc., a biotechnology company, develops small molecule therapies for the treatment of cancer in the United States. The company focuses primarily on developing and commercializing COMETRIQ, an inhibitor of multiple receptor tyrosine kinas... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback